Lab-grown meat, also called cultivated meat, isn’t inherently dangerous, but it’s too early to call it a clear winner over conventional meat on every front. The first products cleared for sale in the U.S. passed FDA safety reviews in 2022 and 2023, and those specific products were produced without antibiotics. Still, open questions remain about nutritional completeness, long-term environmental benefits, and what happens as production scales up.
How Cultivated Meat Is Made
The process starts with a small tissue sample from a living animal or a recently slaughtered one. Scientists isolate stem cells from muscle tissue, then place those cells in a nutrient-rich liquid called growth medium. The cells multiply inside steel vessels similar to those used in brewing beer. Once enough cells have grown, they’re shifted into a different medium that triggers them to mature into muscle fibers, the tissue you’d recognize as meat.
To create something with structure (a chicken breast rather than a paste), producers use edible scaffolds made from materials like gelatin, cellulose, alginate, or plant-based proteins. These are generally recognized as safe for food use. A crosslinking enzyme already common in processed foods helps hold the structure together. The final product is then harvested and handled under USDA food safety oversight, just like conventional meat from that point forward.
Is It Safe to Eat?
The FDA and USDA share regulatory authority over cultivated meat in the U.S. The FDA oversees everything from cell collection through growth and differentiation, then hands off to the USDA for harvesting, processing, and labeling. Before any product reaches the market, it goes through a pre-market consultation where the FDA evaluates the cell lines, manufacturing controls, and every input used in production. Two companies have completed this process so far.
One genuine safety advantage: cultivated meat sidesteps the risks that come with slaughtering animals. There’s no intestinal tract to accidentally contaminate the product, which eliminates the main source of pathogens like Salmonella and E. coli in conventional meat. The sterile bioreactor environment is inherently cleaner than a processing plant handling animal carcasses.
That said, bioreactors have their own contamination risks. Mycoplasma, a type of tiny bacteria, can slip through standard filters and resists most antibiotics used in cell culture. Producers monitor for contamination indirectly by watching for signs of cell damage, but these organisms are notoriously difficult to eliminate once established. Most companies in the industry are developing antibiotic-free production processes, and the products already approved for sale were made without antibiotics during the growth phase. Antibiotics are still commonly used during the initial cell sampling stage.
Cell Mutations and Cancer Concerns
One concern that circulates online is whether eating cells that have mutated in a lab could cause cancer. Cells kept in culture do accumulate genetic mutations over time from replication errors, environmental stress, and aging. These mutations can sometimes promote uncontrolled cell growth, which is technically what happens in cancer. That sounds alarming, but context matters: eating mutated cells is not the same as having mutated cells grow inside your body. Your digestive system breaks down proteins and DNA from food into their basic building blocks. There’s no known mechanism by which eating a mutated cell could transfer that mutation to your own cells.
Still, the industry takes this seriously. Regulators recommend genetic stability testing for starter cell lines, and producers are expected to determine the maximum number of times cells can divide in culture before they change too much. Techniques like whole-genome sequencing and RNA analysis are used to track these changes. The concern is less about consumer safety and more about product consistency: heavily mutated cells may lose their ability to form proper muscle tissue, reducing the nutritional quality of the final product.
Nutritional Gaps Are Still Unclear
Conventional meat is nutritionally dense, providing high-quality protein, iron, zinc, selenium, and B vitamins, especially B12. Whether cultivated meat matches that profile is one of the biggest unanswered questions in the field.
Protein content and composition in cultured cells hasn’t been firmly established as equivalent to traditional meat. Fat is a particular challenge. Producers can co-culture fat cells alongside muscle cells to add fatty acids, but essential fats like linoleic acid and certain compounds like conjugated linoleic acid (found in beef because of the unique digestion process in cattle) may be missing entirely from cultivated products.
Minerals present another gap. Nothing is currently known about how well cultured cells absorb iron, zinc, and selenium from the growth medium. The same uncertainty applies to B vitamins: while vitamins are added to the growth medium to help cells multiply, it’s unclear whether the cells retain enough to match the levels found in a conventional steak or chicken breast. If cultivated meat is going to replace traditional meat in someone’s diet, these gaps would need to be filled, either through the production process itself or through fortification.
The Environmental Picture Is Complicated
Cultivated meat is often promoted as a greener alternative to factory farming, and there are real reasons to think it could be. It doesn’t require grazing land, avoids deforestation, eliminates methane from cattle digestion, and doesn’t produce manure runoff. But the energy demands of running bioreactors complicate the picture significantly.
A life cycle assessment published in ACS Food Science & Technology found that the carbon footprint of cultivated meat varies enormously depending on how the growth medium is prepared. In the best-case scenario, using an unpurified growth medium, cultivated meat produced about 12 kg of CO₂ equivalent per kilogram of product, roughly 80% less than median retail beef (about 60 kg CO₂e per kg). But when the growth medium required pharmaceutical-grade purification, emissions skyrocketed to 246 to 1,508 kg CO₂e per kilogram, which is 4 to 25 times worse than conventional beef.
That range is enormous, and the purification step is the deciding factor. Current production methods often require highly refined ingredients in the growth medium. If the industry can scale up using food-grade rather than pharmaceutical-grade inputs, the climate math improves dramatically. If it can’t, cultivated meat could end up with a larger carbon footprint than the product it’s trying to replace. No comprehensive comparative data on water or land use has been published yet.
The Growth Medium Problem
Early cultivated meat production relied on fetal bovine serum, a product collected from the blood of unborn calves during slaughter. This is a significant ethical and practical problem: it’s expensive, varies from batch to batch, raises animal welfare concerns, and undermines the pitch that cultivated meat reduces animal suffering.
The industry has been working for years to replace it. Alternatives under development include human platelet lysate, plant-derived protein extracts, sericin protein from silkworms, and fully synthetic chemically defined media where every component and its concentration are known. Chemically defined media are already standard in pharmaceutical manufacturing. The products that received FDA clearance were produced without fetal bovine serum, suggesting the industry is moving past this issue, at least for commercial products.
Animal Welfare Tradeoffs
The core promise of cultivated meat is producing large amounts of muscle tissue from very few animals, avoiding the slaughter of billions of livestock each year. Some advocates describe it as “slaughter-free” or “cruelty-free” meat. But animals don’t disappear from the equation entirely.
If production relies on regular biopsies from living donor animals to supply fresh stem cells, those animals will be subjected to repeated tissue sampling throughout their lives, raising its own set of welfare questions. The alternative is developing immortalized cell lines that can divide indefinitely, which requires genetic engineering. These cell lines can originate from a single animal, an embryo, or an umbilical cord, potentially eliminating the need for ongoing animal involvement. Progress on immortalized livestock cell lines has accelerated in recent years, but the technology involves genetic modification, which introduces a separate set of consumer and regulatory concerns.
What This Means Right Now
Cultivated meat that has passed FDA and USDA review is safe to eat based on current evidence. It eliminates real food safety risks associated with conventional slaughter. But it’s a new technology with meaningful unknowns: its nutritional profile hasn’t been proven equivalent to conventional meat, its environmental benefit depends entirely on how it’s manufactured at scale, and the long-term economics remain uncertain. Whether it’s “bad” depends on what you’re comparing it to and which version of the technology eventually reaches your plate. The gap between the best-case and worst-case scenarios for cultivated meat is wider than for almost any other food product on the market.